FDA Panels Will Convene to Weigh Benefit, Safety of CT Colonography Screenings

The FDA will review the effectiveness of CT colonography screenings when its Gastroenterology-Urology and Radiological Devices panels meet next week, according to a Med Page Today report.
The panels, which are subsets of the FDA's Medical Device Advisory Committee, will discuss the safety and benefits of the screenings, as well as its role for asymptomatic patients.

CT colonographies have long been a contested method for colon cancer screening. In 2008, the U.S. Preventative Services Task Force deemed the evidence insufficient to support the screenings while several medical groups called them a good method for testing. CMS has declined to reimburse for "virtual colonoscopies."

More Articles on Gastroenterology:
American College of Gastroenterology Updates Acute Pancreatitis Guidelines
5 GI Devices Receive FDA 510(k) Clearance in August
High Meat Consumption Linked With Barrett's Esophagus Risk

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers